Yanyun Gu
Last active: 1/11/2011


I recieved my MD and master of science in Shanghai Second Medical University in 2003 China.  During my study and practising later on, I developed my interest in Endorine and Metabolic diseases .  Then, I was appointed as assitant physician in  Department of Endocrine and Metabolic diseases in Ruijin Hospital Shanghai, and I got the my  Ph.D.in Medical School of Shanghai Jiao Tong University for Internal Medicine and Endocrinology. My side project in my Ph.D study is to study the adult progenitor for pancreatic β cells.  At that time, I became to realize that to find a new source of pancreatic β cells is the revolutionary therapy for diabetes.  Therefore, in 2007, I joined as a postdoc fellow in Mark.A.Magnuson's lab , whose research accomplishements and interests are mostly focusing on β cell biology and panreatic progenitor cells during pancrease development.  My current research focuses on the function of rictor, which is the major component of mTORC2, in pancreatic islet β cell regeneration and dysfunction.


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Assessing 1-h plasma glucose and shape of the glucose curve during oral glucose tolerance test. Zhou W, Gu Y, Li H, Luo M (2006) Eur J Endocrinol 155(1): 191-7
    › Primary publication · 16793967 (PubMed)
  2. The -822G/A polymorphism in the promoter region of the MAP4K5 gene is associated with reduced risk of type 2 diabetes in Chinese Hans from Shanghai. Gu Y, Luo T, Yang J, Zhang D, Dai M, Jian W, Zheng S, Zhou W, Zhou W, Wu Y, Liu Y, Liu Y, Li J, Xie X, Li G, Luo M (2006) J Hum Genet 51(7): 605-10
    › Primary publication · 16699725 (PubMed)
  3. [Clinical and molecular research in a case of familial Carney complex]. Gu YY, Chen Y, Song HD, Li XY, Luo TH, Qiao JO, Zhang Y, Xiao JC, Zhu Y, Zhao YJ, Luo BY, Ning G (2004) Zhonghua Nei Ke Za Zhi 43(10): 764-8
    › Primary publication · 15631831 (PubMed)